ABSTRACT Thallium-201 (201T1) uptake and redistribution kinetics were examined in an open-chest canine preparation of occlusion and reperfusion. Seven dogs (group I) underwent 3 hr of sustained occlusion and received 1.5 mCi of 201TI after 40 min of occlusion of the left anterior descending coronary artery (LAD). Group II (n = 18) underwent 60 min of LAD occlusion followed by sudden and total release of the ligature. Group lla (n = 8) received intravenous 201T1 during occlusion of the LAD, whereas group JIb (n 10) received intravenous 201T1 at the time of peak reflow. Group III dogs (n = 26) also underwent 60 min of LAD occlusion that was followed by gradual reflow through a residual critical stenosis. Animals in this group also received 20MT1 either before (Illa; n = 16) or after reflow was established (IlIb; n = 10). In group I, the relative 201T1 gradient (nonischemic minus ischemic activity) decreased from 88 + 8% (mean + SEM) to 59 + 6% during 3 hr of coronary occlusion (p = .034). After rapid and total reperfusion (group lla), this gradient decreased from 71 + 6% during occlusion to 26 + 5% after reflow (p < .001). After slow reperfusion through a residual stenosis (group Illa), the gradient decreased from 81 ± 5% to 31 ± 5% (p < .001) (p = .56 compared with group Ha). In rapidly reperfused dogs receiving intravenous thallium during peak reflow (Ilb), initial 201T1 activity in the ischemic zone was 155 ± 20% of initial normal activity and fell to 93 ± 13% of normal after 2 hr of reperfusion. Similarly, in dogs reperfused slowly through a critical stenosis (IlIb), which received 201T1 during reflow, 201T1 activity soon after reflow was 94 ± 4% of initial normal and decreased to 80 + 6% at 2 hr of reperfusion (p = .10). Histochemical evidence of necrosis was present in the biopsy region in 80% of the 20 dogs subjected to triphenyl tetrazolium chloride (TTC) staining. Microsphere-determined transmural blood flow was similar in all groups during LAD occlusion and final flows after 2 hr were comparable in all subgroups undergoing reflow. Ischemic zone flow (% normal) was significantly higher at the time of 201TI administration in groups Ilb (192 ± 25%) and IfIb (1 10 + 5%), which received 201T1 during reflow, than in groups lla (31 ± 9%) and Illa (22 + 5%), which received 201T1 during occlusion. These differences in flow at the time of administration of 20MT1 explain the different thallium uptake patterns observed. These data suggest that after 1 hr of LAD occlusion there is no difference between rapid reperfusion through a totally patent vessel and slow reperfusion through a critical stenosis with regard to ultimate degree of flow restoration or magnitude of 201T1 redistribution in instances in which 201T1 is given before reflow. With both methods of reperfusion a residual 201T1 gradient is seen. Administration of 201T1 during reflow, however, probably overestimates the degree of myocardial salvage as reflected by final 201T1 uptake values. In dogs rapidly reperfused, a relative "hot spot"' of 201T1 activity was observed in the ischemic zone when 201T1 was administered at peak reflow, despite histochemical evidence of necrosis. These results have clinical implications with respect to the timing of 201T1 administration and interpretation of serial 201T1 scintigrams in patients with acute myocardial infarction undergoing thrombolysis.
reflow was established (IlIb; n = 10). In group I, the relative 201T1 gradient (nonischemic minus ischemic activity) decreased from 88 + 8% (mean + SEM) to 59 + 6% during 3 hr of coronary occlusion (p = .034). After rapid and total reperfusion (group lla), this gradient decreased from 71 + 6% during occlusion to 26 + 5% after reflow (p < .001). After slow reperfusion through a residual stenosis (group Illa), the gradient decreased from 81 ± 5% to 31 ± 5% (p < .001) (p = .56 compared with group Ha). In rapidly reperfused dogs receiving intravenous thallium during peak reflow (Ilb), initial 201T1 activity in the ischemic zone was 155 ± 20% of initial normal activity and fell to 93 ± 13% of normal after 2 hr of reperfusion. Similarly, in dogs reperfused slowly through a critical stenosis (IlIb), which received 201T1 during reflow, 201T1 activity soon after reflow was 94 ± 4% of initial normal and decreased to 80 + 6% at 2 hr of reperfusion (p = .10). Histochemical evidence of necrosis was present in the biopsy region in 80% of the 20 dogs subjected to triphenyl tetrazolium chloride (TTC) staining. Microsphere-determined transmural blood flow was similar in all groups during LAD occlusion and final flows after 2 hr were comparable in all subgroups undergoing reflow. Ischemic zone flow (% normal) was significantly higher at the time of 201TI administration in groups Ilb (192 ± 25%) and IfIb (1 10 + 5%), which received 201T1 during reflow, than in groups lla (31 ± 9%) and Illa (22 + 5%) , which received 201T1 during occlusion. These differences in flow at the time of administration of 20MT1 explain the different thallium uptake patterns observed. These data suggest that after 1 hr of LAD occlusion there is no difference between rapid reperfusion through a totally patent vessel and slow reperfusion through a critical stenosis with regard to ultimate degree of flow restoration or magnitude of region over 2 to 4 hr has been thought to be an indication of underperfused but viable myocardium.3 In contrast, a pronounced defect in 201T1 uptake that remains persistent over 2 to 4 hr after 201T1 administration is suggestive of irreversibly injured myocardium.6 With the recent availability of thrombolytic agents for clinical use, several groups have begun to employ 201T1 myocardial scintigraphy to assess the extent of reflow and salvage after coronary reperfusion.7-15 The mode and times of 201T1 administration and the approach to the analysis of myocardial distribution of thallium have varied considerably in both experimental and clinical protocols assessing the efficacy of coronary reperfusion.
In experimental preparations of reperfusion, rapid reflow through a totally patent vessel has been shown to be associated with myocyte swelling,16 myocardial hemorrhage, and edema.'1'9 These consequences of microvascular damage may not only limit the amount of reperfusion achieved in the ischemic bed, but may also be associated with significant alterations in myocardial extravascular compartments that could influence 201T1 uptake and washout kinetics. Clinical reperfusion with thrombolytic agents usually occurs as clot lysis progresses over 20 to 30 min and is frequently associated with a residual critical stenosis in the infarct vessel.20 Under these conditions, 201T1 uptake and washout patterns, changes in regional myocardial blood flow, and the degree of myocardial salvage may not reflect the situation of total coronary occlusion followed by rapid reflow through a totally patent vessel.
Accordingly, we sought to compare the effects of slow reperfusion through a critical stenosis with rapid reflow through a totally patent vessel on regional myocardial blood flow and 201T1 uptake and washout kinetics. Using these models, we administered 201T1 intravenously either during the period of coronary occlusion or soon after reflow, and then assessed the changes in 201Tl activity in nonischemic and ischemic myocardial regions for 2 hr after reperfusion.
Methods
Animal preparation. Experiments were performed in mongrel dogs (20 to 30kg) that were fasted for 24 hr before surgery. Animals were anesthetized with pentobarbital sodium (30 mg/kg iv), after which intubation was accomplished. The dogs were then placed on a Harvard Apparatus respirator, set at a rate of 13/min and a tidal volume of 500 ml. Arterial blood gases were frequently monitored and the respirator was adjusted as necessary to maintain the arterial Po2 and pH within the normal physiologic range. Small additional doses of pentobarbital were periodically administered when necessary. Care was taken to ensure that pentobarbital was not given during or near the time of administration of microspheres or 20ITI or at the time of hemodynamic recording. A limb lead of the electrocardiogram was monitored continuously, with 18-gauge stainless steel needles inserted subcutaneously used as leads. A femoral vein was isolated and a polyethylene catheter (Intramedic No. 7450) was inserted for administration of fluids and 20IT1. This intravenous line was kept open with a 5% dextrose, 0.9% saline solution infused at a rate sufficient to maintain the left atrial filling pressure and arterial blood pressure at constant levels during the control state.
Catheters were introduced into both femoral arteries after cutdowns and were advanced to the aortic arch. These catheters were used to withdraw simultaneous reference blood samples for microsphere analysis as well as for monitoring central aortic pressure.
A thoracotomy was performed in the fifth left intercostal space of each dog, the pericardium was opened, and a "cradle" was established for suspension of the heart. The proximal portion of the left anterior descending coronary artery (LAD) was then dissected free of the epicardium and a hydraulic occluder (Rhodes Medical Instruments, Model VO-3) was placed around the vessel. An appropriately sized electromagentic flow probe (Carolina Instruments) was fitted distal to the occluder in each animal. A 22-gauge angiographic catheter (Desseret) was iserted into a distal branch of the LAD and connected to a HewlettPackard 1280 pressure transducer to continuously monitor the distal coronary perfusion pressure throughout the experiments. A flared polyethylene tube was placed in the left atrial appendage for pressure measurement and for the injection of radiolabeled microspheres. Zero calibration for the electromagnetic flowmeter (EMF) was performed by brief occlusion of the LAD.
Experimental design
Instrumentation. In 18 dogs undergoing slow reperfusion, a partially tightened ligature was placed around the vessel just distal to the hydraulic cuff occluder. This ligature was progressively tightened to produce a critical stenosis as defined by the absence of the reactive hyperemic responsive after a 10 sec occlusion with the snare. In another eight dogs also selected to undergo slow reperfusion, a ligature-type stenosis was not used. Instead, the hydraulic cuff occluder was calibrated such that it opened no further than the previously defined critical stenosis. 
Results
Hemodynamics. Figure 2 summarizes the serial hemodynamic measurements made during the experiment in groups I, lla, and Illa. Dogs receiving 21T1 during reflow (groups lIb and IlIb) had a similar hemodynamic profile. While the heart rate remained similar and constant in animals undergoing either rapid or slow reperfusion, dogs with a 3 hr sustained occlusion (group I) had a significantly higher heart rate at the end of the experiment (p < .001). Mean arterial pressure was similar in all three groups. LAD flow by the EMF was undetectable throughout the period of the 3 hr occlusion in group I dogs. Rapid reperfusion (group II) resulted in peak flows 5 min after reflow rising to three times control (p < .0001), whereas slow reperfusion through a critical stenosis ( Figure 4 shows the myocardial 201TI time-activity curves from the transmural biopsies obtained in the central ischemic and normal myocardial regions in dogs undergoing 3 hr of sustained LAD occlusion. After 55 min of LAD occlusion 20ITI activity in the ischemic region was reduced to 12 ± 2% of normal and remained low (10 + 3%) at 3 hr of occlusion. During this time period, the relative gradient in 201T1 activity between nonischemic and ischemic zones (nonischemic minus ischemic activity) decreased from 88 ± 8% after 55 min of occlusion to 59 ± 6% after 3 hr of coronary occlusion (p = .034). Initial nonischemic activity was normalized to 100%. As depicted in figure 4, this reduction was primarily due to 201T1 washout from normal myocardium, which decreased the gradient between the two Figure 5 shows the 201T1 time-activity curves from ischemic and normal myocardium for this group before and after sudden and total release of the LAD occlusion. After 55 min of occlusion 201T1 activity in the central ischemic zone was 29 Figure 6 shows the myocardial 201T1 time-activity curves from ischemic and normal myocardium when 201T1 was administered intravenously soon after total release of the LAD ligature. Ten reperfusion values observed in the groups that received 201T1 before reflow. This method of administration of 201T1 actually produced a relative "hot spot," with early 201Tl activity in the ischemic zone significantly exceeding that in the normal zone. This increased uptake was followed by rapid washout of 201T1 (figure 6). Because of this rapid washout, no significant difference between 201T1 activity in the normal and ischemic zone was ultimately observed after 2 hr of reflow. Thus, the configuration of these 201T1 activity curves (figure 6) were quite different than the curves obtained when 211Tl was given during occlusion and partial redistribution was observed (figure 5) NARY OCCLUSION. Figure 7 shows the myocardial 201T1 time-activity curves from ischemic and normal myocardium in dogs undergoing 1 hr of LAD occlusion followed by slow reperfusion through the residual critical stenosis. In these dogs 201T1 was given after 40 min of LAD occlusion, similar to the protocol followed for the rapid and totally reperfused group. After .001). The decrease in the gradient is due to a combination of delayed 20IT1 accumulation in the ischemic region and washout of 201T1 from the normal myocardium, as was observed in the rapid and totally reperfused groups. This final gradient was similar to that measured in dogs in group lla that underwent rapid and total reperfusion.
IIIB: INTRAVENOUS ADMINISTRATION OF '01TL DURING PEAK
REFLOW. Figure 8 shows the 201T1 time-activity curves from ischemic and normal myocardium in dogs undergoing slow reperfusion through a critical stenosis and given 201TI intravenously after completion of the 30 min reflow period. The first biopsy values showed only a 5% difference in'°'Tl activity between nonischemic and central ischemic zones. 201T1 activity in the ischemic zone in these dogs was significantly lower Figure 9 compares the initial and final 201TI gradients (nonischemic activity minus ischemic zone activity) for each of the experiments. As can be seen from figure 9 , the initial 20ITI gradient was similar in groups I, lla, and Illa in which 20'T1 was administered intravenously during LAD occlusion. After reperfusion, in groups lla and Illa there was a reduction in 21 'T gradient that was significantly smaller than the residual 201TI gradient that was seen in dogs undergoing sustained LAD occlusion (group I). through a critical stenosis (group IlIb) only a small 201TI gradient was initially noted between ischemic and normal myocardium. With further duration of reperfusion, this gradient increased slightly but not to the point seen when 201TI was administered before reflow. Thus, in identical preparations of occlusion and reperfusion, differences in the timing of 201T1 administration may result in vast differences in initial and final myocardial 201T1 gradients.
Myocardial 201T1 uptake and clearance rates. The slope of the myocardial time activity curve is related to net myocardial uptake or clearance rate. Table 1 , lists the slope of the 20oTl time-activity curve between each biopsy point for all groups. Positive slopes represent 20oTl uptake, whereas negative slopes represent 201T1 washout. In the normal zone, there was a slight but significant difference in the early washout of 201T1 between group lla at -0.0070 ± 0.002% activity/min and group Illa at -0.0020 ± 0.001% activity/min (p = .01). Normal zone washout was comparable in all groups during the latter portion of the reflow period. Ischemic zone washout rates varied considerably during the early portion of reperfusion. Groups lla and Illa received 20ITI during occlusion and exhibited net 2otTl uptake during the early reperfusion period at rates of + 0.0032 + 0.003% and + 0.0024 ± 0.002% activity/min. This is in distinct contrast to group lIb and IlIb dogs, which received 201TI during reperfusion and exhibited net 20oTl washout in the ischemic zone during the early reperfusion period at rates of -0.0200 ± 0.002% and -0.0020 ± 0.003% activity/min (p -.0003). There was no significant difference in ischemic zone I01TI clearance rates in the late reperfusion period.
Histochemical staining. In group I (3 hr of sustained occlusion), histochemical evidence of myocardial necrosis was seen in the biopsy region in all five dogs. Necrosis involved most of the endocardium and mid TABLE 1 epicardium, and was frequently transmural. Infarct size averaged 31 ± 3% of the left ventricle by weight. In group II dogs (rapid reperfusion), histochemical evidence of myocardial necrosis in the biopsy region was evident in six of seven samples stained. The area of necrosis was usually confined to the endocardial regions and frequently showed signs of gross hemorrhage. Infarct size averaged 4.2 ± 1% of the left ventricle. Similarly, in the group III dogs that underwent slow reperfusion through a critical stenosis, histochemical evidence of myocardial necrosis was seen in the region biopsied in nine of the 13 cases (p = NS compared with group II). Infarct size in this group averaged 3.2 ± 1% of the left ventricle by weight. Again, the area of necrosis was usually confined to the endocardial region and gross hemorrhage was readily apparent.
Discussion
In the present study, we examined myocardial 20oTl uptake and washout kinetics in two separate preparations of experimental reperfusion after intravenous administration of 201T1. When 201T1 was given during coronary occlusion and before reflow the initial myocardial 20 A difference in the configuration of the time-activity curves between fast and slowly reperfused dogs receiving 201T1 before reflow is apparent (figures 5 and 7). This difference is primarily due to the slope of the early portion of the nonischemic 201TI washout curve. There was no significant difference in the latter portion of the curves from the second to the final biopsy point. Caution must be exercised in making inferences from linear fits of three points to what is probably an exponential process.5 The slopes of the early portion of the nonischemic 201T1 time-activity curves for groups of dogs receiving 201T1 during reperfusion (figures 6 and 8) are different from the slopes in dogs receiving 201T1 during occlusion ( figures 5 and 7) . Again, the latter points of the time-activity curves had similar slopes and the observed differences in the early washout rates may be random. In dogs receiving 201T1 during the occlusion phase, the time-activity curves from the ischemic zone are upsloping and give some indication of the rate of delayed 201TI uptake after reperfusion.
The slopes of the initial portions of the ischemic zone time-activity curves are different in dogs subjected to rapid reperfusion through a totally patent vessel (group lla) and those undergoing slow reperfusion through a residual stenosis (group Illa), implying that the rate and magnitude of reflow (soon after release of the occlusion) may reperfusion failed to delineate defects that were apparent on scintigraphy 48 hr later. 14 Necrosis in the zones corresponding to the demonstrated defects was documented by TTC staining. Also, if coronary reperfusion is instituted too soon after intravenous administration of 201T1, "excess" 201T1 uptake followed by rapid washout may be observed in the ischemic zone since blood levels of 201T1 have not yet appreciably declined to a plateau.29' 30 Rapid washout of 201T1 has been observed after either reactive' or vasodilator-induced hyperemia,31 and in reperfused myocardial infarcts. 26 In spite of an accelerated early 201T1 washout from the reperfused ischemic zone in our study (figure 6), final 201T1 activity at 2 hr remains high and is not significantly different from the activity in the normal zone. This normalization of 201T1 activity in the ischemic zone certainly masked the extent of myocardial injury since the amount of necrosis was comparable to that seen in the group of dogs undergoing a similar duration of occlusion and reperfusion but receiving 201T1 before reflow in which a final 201T1 gradient (partial redistribution) was observed.
Clinical implications. This study has clinical implications with regard to the administration of 201T1 and subsequent imaging techniques for assessing efficacy of coronary reperfusion with thrombolytic therapy. This work provides experimental validation of the methods of Reduto, Simoons, and DeCoster and their colleagues,11' 12, 15 who administered 20MT1 intravenously during acute coronary occlusion followed by clinical thrombolysis. Each of these studies has shown that successful thrombolysis is associated with 201T1 redistribution and smaller 201T1 defect size.
Our data suggest that after 1 hr of coronary occlusion there is no significant difference in degree of restoration of regional blood flow and final myocardial 201T1 activity in the central ischemic zone between dogs undergoing rapid reperfusion through a patent vessel and those undergoing slow reperfusion through a critical stenosis at 2 hr of reflow. Our data further indicate that administration of 201T1 immediately after reperfusion results in excessively high 201T1 uptake with subsequent rapid washout. This may explain normal 201T1 uptake in infarct zones seen on scintigrams obtained soon after thrombolysis with direct intracoronary administration of thallium. Our data and those of others suggest that the amount of viable tissue present after reperfusion could be overestimated when 201T1 is given for the first time immediately after reperfusion, whereas intravenous administration of 20MT1 during occlusion results in uptake and washout patterns that allow the observation of 201T1 redistribution after reperfusion.
The greater the degree of redistribution and defect resolution, the more likely myocardial salvage was accomplished.
In human coronary reperfusion, a smaller 201T1 defect after reperfusion may not always represent salvage secondary to successful reflow. Enhanced collateral blood flow32 and alterations in left ventricular volume33 have been shown to affect size of the 201T1 defect. Finally, prolonged cellular metabolic abnormalities consequent to ischemia in the absence of necrosis ("stunned" myocardium) might adversely influence 201T1 uptake and washout patterns soon after reperfusion such that repeat imaging 2 to 3 weeks later could show a substantially smaller 201T1 defect. Knowledge of the diverse 201T1 uptake and washout kinetics seen with different methods of reperfusion and different modes of administration of thallium should assist in the interpretation of clinical scintigrams when this radionuclide technique is employed for serial assessment of perfusion and viability in patients undergoing thrombolytic therapy.
